ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, announced today that a study conducted by researchers at Rush University Medical Center shows a BioCleanse®-sterilized meniscus performs the same as an aseptically processed meniscus, while providing additional implant safety through sterilization. The implants used in the study were sterilized through RTI’s patented BioCleanse® Tissue Sterilization Process.
